Conversely, tumor growth is favored by SIRT3 ablation in several mice models, and a tumor suppressor role of SIRT3 has been reported in breast cancer, hepatocellular carcinoma, metastatic ovarian cancer and B-cell malignancies [17, 21]. This evidence concerns the gene SIRT3 and breast carcinoma.